Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
09/2014
09/25/2014WO2014149266A2 Methods and acellular compositions for treating inflammatory disorders
09/25/2014WO2014149001A1 STAPLING eIF4E INTERACTING PEPTIDES
09/25/2014WO2014148932A2 Aspartic proteases
09/25/2014WO2014148620A1 Double-stranded nucleic acid binder, said binder—double-stranded nucleic acid complex, pharmaceutical composition containing said complex, and production method for said complex
09/25/2014WO2014148489A1 Cyclic peptide
09/25/2014WO2014148438A1 Therapeutic agent for hepatitis c which comprises 4-(1,1,1,3,3,3-hexafluoro-2-hydroxypropan-2-yl)benzene derivative
09/25/2014WO2014147622A1 Compositions comprising collagen and prp for tissue regeneration
09/25/2014WO2014147597A1 Aminofucoidan as a vector for fibrinolysis in thrombotic diseases
09/25/2014WO2014147489A2 Recombinant human albumin-human granulocyte colony stimulating factor for the prevention of neutropenia in pediatric patients
09/25/2014WO2014147405A1 Combination comprising zidovudine and polymyxin
09/25/2014WO2014147383A1 Peptides and uses thereof
09/25/2014WO2014147246A1 Method and pharmaceutical composition for use in the treatment of chronic liver diseases associated with a low hepcidin expression
09/25/2014WO2014147141A1 Insulin dosing regimen
09/25/2014WO2014147092A1 Implantable preparations for regeneration of tissues and treatment of wounds, their method of preparation, and method of treatment of patients with said implantable preparations
09/25/2014WO2014146677A1 Peg hydrogels functionalized with glucagon and rgds-tetrapeptide and containing stem cells for islet coating
09/25/2014US20140288267 Compositions and methods for modulating rsv infection and immunity
09/25/2014US20140288266 Synthesis of Cyclosporin Analogs
09/25/2014US20140288162 Methods, compositions and screens for therapeutics for the treatment of synovial sarcoma
09/25/2014US20140288161 Urocortin-iii and uses thereof
09/25/2014US20140288012 Methods for the prevention and treatment of burn injuries and secondary complications
09/25/2014US20140288010 Compositions and Methods for Increasing Stem Cell Survival
09/25/2014US20140288004 Lactoferrin and the white matter
09/25/2014US20140288001 Kallikrein inhibitors and anti-thrombolytic agents and uses thereof
09/25/2014US20140288000 Dual reactivity potent kunitz inhibitor of fibrinolysis
09/25/2014US20140287999 Use of Natriuretic Peptide for Treating Heart Failure
09/25/2014US20140287998 Glucagon formulations
09/25/2014US20140287997 Use of growth hormone or growth hormone receptor agonists to prevent or treat stress-sensitive psychiatric illness
09/25/2014US20140287996 Neuroprotection by hepatic cells and hepatocyte secretory factors
09/25/2014US20140287995 Stable pharmaceutical formulations of growth factor peptides
09/25/2014US20140287993 Aminotetrahydropyrans as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes
09/25/2014US20140287991 Hepatitis B Virus-Binding Polypeptides and Methods of Use Thereof
09/25/2014US20140287990 Compositions and methods to concurrently treat and/or prevent multiple diseases with cupredoxins
09/25/2014US20140287988 Macrogol 15 hydroxystearate formulations
09/25/2014US20140287984 Polyethylene glycol based prodrug of adrenomedullin and use thereof
09/25/2014US20140287983 Antisense compositions and methods for modulating contact hypersensitivity or contact dermatitis
09/25/2014US20140287497 Methods of Modulating Cold Sensory Perception
09/25/2014US20140287457 Synthetic genes for plant gums and other hydroxyproline-rich glycoproteins
09/25/2014US20140287071 Veterinary supplements
09/25/2014US20140287057 Dietary product intended for the prevention of cardiometabolic risk
09/25/2014US20140287056 Use of whey protein micelles for infants at risk of obesity or diabetes
09/25/2014US20140287054 Composition comprising bioactive amino acids and/or peptides and marine oil in a stable oil-in-water emulsion, and the use of said composition as a functional or therapeutic composition
09/25/2014US20140287045 Method of preparing microspheres by using polymer having sol-gel transition property and microspheres prepared thereby
09/25/2014US20140287044 Fibrin sealant (fibringluraas) consisting of a kit of lyophilized or frozen high concentrate fribinogen
09/25/2014US20140287035 Pancreatic enzyme compositions and methods for treating pancreatitis and pancreatic insufficiency
09/25/2014US20140287034 Stable Solid Formulation of a GC-C Receptor Agonist Polypeptide Suitable for Oral Administration
09/25/2014US20140287033 Lipid therapy
09/25/2014US20140287032 Treatment Method and Product for Uterine Fibroids using Purified Collagenase
09/25/2014US20140287029 Immunogenic epitopes of ngep antigen
09/25/2014US20140287015 Ceramidase and cell differentiation
09/25/2014US20140287006 Degradation-Stabilised, Biocompatible Collagen Matrices
09/25/2014US20140287002 Agonists Of Guanylate Cyclase And Their Uses
09/25/2014US20140287001 Compositions Useful For The Treatment Of Gastrointestinal Disorders
09/25/2014US20140286968 Antibody drug conjugate (adc) purification
09/25/2014US20140286966 Methods and compositions for the treatment of metabolic syndrome, obstructive respiratory disorders, cancer and related diseases
09/25/2014US20140286962 Reagents and methods for detecting pnh type ii white blood cells and their identification as risk factors for thrombotic disorders
09/25/2014US20140286954 Tau protease compositions and methods of use
09/25/2014US20140286953 Hepcidin, hepcidin antagonists and methods of use
09/25/2014US20140286948 Methods for treating scleroderma by administering a soluble ctla4 molecule
09/25/2014US20140286932 Giant Obscurins and Uses Thereof in Cancer Prognosis and Therapy
09/25/2014US20140286930 Treatment of Mammalian Physiological Reaction of IgE Antibodies Present in Said Mammal Upon Contact with the Corresponding Antigen
09/25/2014US20140286929 Proteomic ipf markers
09/25/2014US20140286928 Treatment of heart disease by inhibition of the action of ribosomal s6 kinase 3 (rsk3)
09/25/2014US20140286927 Method for the treatment of ulcerative colitis in patients refractory to steroid therapy using leached ligand fibrin stabilizing composition
09/25/2014US20140286926 Method for treatment or prevention of allergic diseases
09/25/2014US20140286924 Agent for use in the case of disorders of blood sugar metabolism, including diabetes
09/25/2014US20140286923 Nutritional supplement for weight management
09/25/2014US20140286916 Uses of Growth and Differentiation Factor 8 (GDF-8)
09/25/2014US20140286914 Protein therapy for treatment of eye diseases
09/25/2014US20140286906 Use of igf-1 in the modulation of treg cell activity and the treatment and prevention of autoimmune disorders or diseases
09/25/2014US20140286901 Methods, Pharmaceutical Compositions and Kits for Use in the Treatment of Adult T-Cell Leukemia/Lymphoma
09/25/2014US20140286900 2'-branched nucleosides and flaviviridae mutation
09/25/2014US20140286897 Compositions and Methods for the Regulation of T Regulatory Cells Using TL1A-Ig Fusion Protein
09/25/2014US20140286895 Methods and Compositions for Promoting Organ Development
09/25/2014US20140286884 Composition using cross-linked hyaluronic acid for topical cosmetic and therapeutic applications
09/25/2014US20140286864 Kdr and vegf/kdr binding peptides and their use in diagnosis and therapy
09/25/2014US20140286859 Psma antibodies and uses thereof
09/24/2014EP2781525A2 Novel derivatives of hemin with antibacterial and antiviral activity
09/24/2014EP2781524A1 Compositions and methods for inhibiting viral adhesion
09/24/2014EP2781224A1 Implantable preparations comrpsing globin insoluble at physiological pH and serum for regeneration of tissues and treatment of wounds.
09/24/2014EP2781223A1 Compositions comprising semaphorins for the treatment of angiogenesis related diseases
09/24/2014EP2781222A1 Activin-ActRIIA antagonists in use for promoting bone growth
09/24/2014EP2781221A1 Medicine for treatment and/or improvement of sepsis
09/24/2014EP2781213A1 Method of preparing microspheres by using polymer having sol-gel transition property and microspheres prepared thereby
09/24/2014EP2781212A1 Long-acting formulations of insulins
09/24/2014EP2780457A1 Use of fibromodulin and lumican for increasing muscle mass
09/24/2014EP2780376A1 Methods and products for increasing frataxin levels and uses thereof
09/24/2014EP2780365A1 Lactoferrin derived peptides for use as broad- spectrum inhibitors of influenza virus infection
09/24/2014EP2780363A2 Compositions and methods for treating glioma
09/24/2014EP2780361A1 Conjugates of gm-csf and il-7, compositions and methods related thereto
09/24/2014EP2780360A1 Compositions and methods for treating autoimmune and inflammatory disorders
09/24/2014EP2780359A1 Cationic antibacterial composition
09/24/2014EP2780358A1 Cyclosporine a form 2 and method of making same
09/24/2014EP2780357A1 Polymyxin derivatives
09/24/2014EP2780356A1 Peptides that inhibit the interaction between asf1 and histones, and use thereof
09/24/2014EP2780032A1 Chewable wafers containing lipid supplements for maintaining health and the treatment of acute and chronic disorders
09/24/2014EP2780031A1 Glucagon superfamily peptides exhibiting glucocorticoid receptor activity
09/24/2014EP2780029A1 Oral leptin formulations and uses thereof
09/24/2014EP2780028A1 Use of protein s for treating cancer
09/24/2014EP2780027A1 Apoaequorin for reducing neuronal injury due to ischemia
09/24/2014EP2780026A2 Hcv ns3 protease inhibitors
1 ... 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 ... 3163